BackElectra Therapeutics Overview

Electra Therapeutics Current Cash

Track Electra Therapeutics's current cash ($67M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$66.51M

Peer trimmed avg / median

Loading

Electra Therapeutics Current Cash History

Loading

Electra Therapeutics vs. peers: Current Cash Comparison

Loading

Electra Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Electra Therapeutics (ETRA) FAQ

Electra Therapeutics posts a current cash of $67M as of June 2026. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Current Cash is one piece of Electra Therapeutics's financial statement story. At $67M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ETRA's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Electra Therapeutics's other metric pages and overview cover the third.